共 50 条
Hidradenitis suppurativa
被引:3
|作者:
Gonzalez-Lopez, Marcos A.
[1
,2
,3
,4
]
机构:
[1] Hosp Univ Marques de Valdecilla, Serv Dermatol, Santander, Cantabria, Spain
[2] Univ Cantabria, Dept Med & Psiquiatria, Santander, Cantabria, Spain
[3] Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain
[4] Real Acad Med Cantabria, Santander, Cantabria, Spain
来源:
MEDICINA CLINICA
|
2024年
/
162卷
/
04期
关键词:
Hidradenitis suppurativa;
Acne inversa;
Immune-mediated diseases;
Chronic inflammation;
Comorbidities;
SEVERITY ASSESSMENT;
SCORING SYSTEM;
DIAGNOSIS;
D O I:
10.1016/j.medcli.2023.09.018
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory disease derived from the pilosebaceous unit, that affects approximately 1% of the general population. Clinically, it is characterized by inflammatory nodules, abscesses, and tunnels in the intertriginous areas of the body, especially in the axillary, inguinal, and anogenital regions. The etiopathogenesis of HS is not completely understood, although it is considered to be multifactorial, and the result of a complex interaction between genetic, hormonal, environmental, and immunological factors. In this sense, several proinflammatory cytokines, such as tumor necrosis factor -alpha (TNF-a), interleukin (IL) -L -1p, and IL -17, among others, appear to play a crucial role in the pathogenesis of the disease. Currently, HS is recognized as a systemic disease associated with numerous comorbidities, including cardiovascular, immune -mediated, and endocrinemetabolic diseases. The treatment of HS must be carried out with an individualized and patient -oriented approach, considering medical and surgical treatment modalities. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文